SmileDirectClub Total Non-Operating Income/Expense 2018-2023 | SDCCQ
SmileDirectClub total non-operating income/expense from 2018 to 2023. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
SmileDirectClub Annual Total Non-Operating Income/Expense
(Millions of US $) |
| 2022 |
$-16 |
| 2021 |
$-75 |
| 2020 |
$-58 |
| 2019 |
$-45 |
| 2018 |
$-29 |
| 2017 |
$-2 |
SmileDirectClub Quarterly Total Non-Operating Income/Expense
(Millions of US $) |
| 2023-06-30 |
$-8 |
| 2023-03-31 |
$-6 |
| 2022-12-31 |
$4 |
| 2022-09-30 |
$-7 |
| 2022-06-30 |
$-10 |
| 2022-03-31 |
$-3 |
| 2021-12-31 |
$-2 |
| 2021-09-30 |
$-4 |
| 2021-06-30 |
$-2 |
| 2021-03-31 |
$-66 |
| 2020-12-31 |
$-12 |
| 2020-09-30 |
$-15 |
| 2020-06-30 |
$-22 |
| 2020-03-31 |
$-9 |
| 2019-12-31 |
$-3 |
| 2019-09-30 |
$-5 |
| 2019-06-30 |
$-33 |
| 2019-03-31 |
$-4 |
| 2018-12-31 |
|
| 2018-09-30 |
$-11 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.000B |
$0.471B |
|
SmileDirectClub, Inc. is an oral care company and claims to be the creator of the first MedTech platform for teeth straightening. By its new teledentistry technology and vertically integrated model, it's playing a key role in the oral care industry. It offers professional-level service and high-quality doctor's reviewed clear aligners at a low cost. It has developed a number of proprietary processes and technologies, like complex software solutions, laser, destructive & white light scanning techniques, stereolithography, 3D printing, and thermoforming. The manufacturing is performed by Access Dental Lab, LLC, its wholly owned subsidiary. Its proprietary teledentistry platform, SmileCheck enables marketing to aligner manufacturing, fulfillment, treatment by a member's doctor, and monitoring through completion of their treatment. Its financing program, SmilePay is a convenient monthly payment plan. It accepts insurance and is in-network with UnitedHealthcare, Aetna, Anthem, Cigna, Guardian, HUMANA and MetLife.
|
